AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8005121
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg plus Amiloride 2.5 mg (H+Am)
Trial: 8005121
Drug: Nifedipine slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine slow release 20 mg (N)
Trial: 8005121
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg (At)
Trial: 8005121
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg plus Chlorthalidone 6.25 mg (At+C)
Trial: 2511239
Drug: TRH iv
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH iv administration
Trial: 1094965
Drug: Feprazone 600
RxNorm normalized name: feprazone
DrugBank: Feprazone (DB13364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feprazone 600 mg daily
Trial: 1094965
Drug: Aspirin 3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 3.6 g daily
Trial: 23333201
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate 30 mg/kg (Group I)
Trial: 23333201
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate 40 mg/kg (Group II)
Trial: 23333201
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate 50 mg/kg (Group III)
Trial: 23333201
Drug: Lidocaine 1.5
RxNorm normalized name: LIDOCAINE 1.5%/EPI 1:200000 INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1.5 mg/kg (Group IV)
Trial: 27358385
Drug: Granisetron (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (1 mg)
Trial: 16551910
Drug: Dolasetron (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron (12.5 mg) in carriers of the duplication of the CYP2D6 allele
Trial: 8883233
Drug: FEC chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC chemotherapy (cyclophosphamide, epirubicin, 5-fluorouracil)
Trial: 2691129
Drug: Perindopril with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril with diuretic
Trial: 1395119
Drug: Captopril with
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril with diuretic
Trial: 1395119
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment with perindopril
Trial: 3903063
Drug: MOPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP chemotherapy and supradiaphragmatic radiotherapy (40 Gy) for clinical stages IA and II2A
Trial: 3903063
Drug: MOPP or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP or CVPP chemotherapy followed by laparotomy and radiotherapy for clinical stages II3+A and IIB
Trial: 3301699
Drug: Oral polybacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral polybacterial vaccine containing 1.5 X 10(9) killed Haemophilus influenzae per tablet
Trial: 3301699
Drug: Three-monthly courses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-monthly courses of oral polybacterial vaccine
Trial: 3301699
Drug: Increased immunizing
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased immunizing dose (60 fold) without non H. influenzae bacterial species
Trial: 29138181
Drug: GIKI2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIKI2 group (GIK with intensive insulin therapy for 24 hours)
Trial: 29138181
Drug: GIK group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK group (GIK with nonintensive insulin therapy)
Trial: 29138181
Drug: GIKI2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIKI2 group (GIK with intensive insulin therapy)
Trial: 24066604
Drug: Guizhi Fuling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guizhi Fuling capsule high dose
Trial: 24066604
Drug: Guizhi Fuling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guizhi Fuling capsule low dose
Trial: 21397805
Drug: Topical proparacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical proparacaine anesthetic 0.5%
Trial: 16567814
Drug: Fiber-enriched bread
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiber-enriched bread (31.2 g insoluble fiber/day)
Trial: 11029326
Drug: Surfactant (Survanta,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant (Survanta, 100 mg/kg)
Trial: 1443354
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative dose of cefotaxime (Schedule A)
Trial: 1443354
Drug: One preoperative
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One preoperative dose followed by two postoperative doses of cefotaxime (Schedule B)
Trial: 3914879
Drug: Intravenous pindolol
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous pindolol for 24 hours and orally for 48 hours
Trial: 27189973
Drug: BMS-932481 (γ-secretase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-932481 (γ-secretase modulator)
Trial: 18669425
Drug: Cellulose sulfate
RxNorm normalized name: CELLULOSE SULFATE
DrugBank: Microcrystalline cellulose (DB14158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellulose sulfate gel
Trial: 16087822
Drug: Risedronate sodium
RxNorm normalized name: Risedronate Sodium
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risedronate sodium 2.5 mg daily
Trial: 2614521
Drug: 4% lidocaine
RxNorm normalized name: Lidocaine 344 mg TOPICAL PATCH [Pain Relief 4% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% lidocaine cream mixed with 500 mg acid mantle cream
Trial: 2614521
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg acid mantle cream
Trial: 641913
Drug: Combined azathioprine
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined azathioprine and prednisone therapy
Trial: 26848888
Drug: Multicomponent fitness
RxNorm normalized name: dimethicone
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multicomponent fitness training (1 hour, twice per week for 1 year)
Trial: 20435263
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy (angioplasty)
Trial: 17997890
Drug: CIK cells
RxNorm normalized name: Testone CIK KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIK cells treatment
Trial: 17997890
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treatment (VitB4, batilol, leucogen, inosine, stanozolol)
Trial: 15844075
Drug: 9-valent pneumococcal
RxNorm normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9-valent pneumococcal conjugate vaccine (PnCV)
Trial: 2905287
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg prostaglandin E2 in gel
Trial: 2905287
Drug: gel only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gel only as placebo
Trial: 29037226
Drug: Xingnaojing injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xingnaojing injection (XNJ) combined with standard care
Trial: 26226139
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (4 g/d)
Trial: 18427229
Drug: Active physical
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active physical therapy (n=51)
Trial: 18427229
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (n=57)
Trial: 18427229
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (n=59)
Trial: 11304723
Drug: Cefadroxila 500
RxNorm normalized name: cefadroxil 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxila 500 mg capsule
Trial: 11304723
Drug: Cefamox 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefamox 500 mg capsule
Trial: 9207344
Drug: Inactivated hepatitis
RxNorm normalized name: Inactivated hepatitis A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated hepatitis A vaccine (VAQTA)
Trial: 3415398
Drug: Duxil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duxil (30 mg almitrine and 10 mg raubasine, 1 tablet b.i.d.)
Trial: 3415398
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 tablet b.i.d.)
Trial: 25238492
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg/day p.o
Trial: 25238492
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 50 mg p.o when required
Trial: 22160300
Drug: Supplemental melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental melatonin (1 or 3 mg dosages)
Trial: 22245769
Drug: Tetrahydrobiopterin (BH(4))
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrahydrobiopterin (BH(4)) administration
Trial: 12152004
Drug: Rofecoxib, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib, 25 mg daily
Trial: 12152004
Drug: Celecoxib, 200
RxNorm normalized name: Celecoxib, 200 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib, 200 mg twice daily
Trial: 7912878
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg manidipine
Trial: 7912878
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg manidipine
Trial: 31504336
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (quarterly single-dose praziquantel, triple-dose albendazole)
Trial: 30325449
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of intravenous hydrocortisone followed by 0.5 mg of intravenous dexamethasone every 6 h for 4 doses (STER)
Trial: 30325449
Drug: Surgery without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery without steroids (NOSTER)
Trial: 28832978
Drug: Bevacizumab 10
RxNorm normalized name: bevacizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 10 mg/kg intravenously every 2 weeks
Trial: 28832978
Drug: Bevacizumab 10
RxNorm normalized name: bevacizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 10 mg/kg intravenously every 2 weeks plus TRC105 10 mg/kg intravenously every 2 weeks
Trial: 28832978
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum TGFβ levels below the median (<10.6 ng/mL)
Trial: 25183694
Drug: Intervention arm
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention arm (received written and oral explanations on cardiac rehabilitation benefits and eligibility, and a follow-up telephone call 2 weeks after hospital discharge)
Trial: 9170825
Drug: Misoprostol vaginal
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol vaginal tablets
Trial: 18282319
Drug: CATIE (Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness)
Trial: 16810760
Drug: Lamivudine treatment
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine treatment (n = 42)
Trial: 1337607
Drug: Baclofen 15
RxNorm normalized name: baclofen 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen 15 mg
Trial: 1337607
Drug: Naloxone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (4 mg IV bolus plus 10 mg infused over 2 hr)
Trial: 1337607
Drug: Baclofen (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (15 mg)
Trial: 2863541
Drug: Non-warfarin (control)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-warfarin (control)
Trial: 10490723
Drug: G‐CSF started
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF started on day 0 (day 0 group)
Trial: 10490723
Drug: G‐CSF started
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF started on day 5 (day 5 group)
Trial: 1748141
Drug: Org 10172
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 10172 (bolus injection of 3250 anti‐Xa units)
Trial: 1748141
Drug: Digoxin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (0.25 mg once daily for 8 days)
Trial: 1748141
Drug: Org 10172
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 10172 and Digoxin combination
Trial: 6803946
Drug: Repeat oral
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeat oral cholecystography
Trial: 28720139
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intramuscular/intra-articular prednisolone, methotrexate (MTX), and golimumab (GOL) for 24 weeks
Trial: 28720139
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intramuscular/intra-articular prednisolone, methotrexate (MTX), and placebo for 24 weeks
Trial: 26829760
Drug: Manual Lymphatic
RxNorm normalized name: PINPOINT Lymphatics Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual Lymphatic Drainage (MLD) treatments (5 sessions)
Trial: 21371166
Drug: Dexmedetomidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.5 μg·kg(‐1))
Trial: 21371166
Drug: Midazolam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.1 mg·kg(‐1))
Trial: 17874530
Drug: Low-dose fixed
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fixed combination of perindopril and indapamide
Trial: 17874530
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy for blood glucose control
Trial: 14687174
Drug: Low-dose octreotide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose octreotide
Trial: 3632149
Drug: Therapeutic drug
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic drug monitoring program for digoxin
Trial: 3632149
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of therapeutic drug monitoring program
Trial: 26644536
Drug: Cetuximab (CTX)
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab (CTX) 400 mg/m2 as loading dose followed by 250 mg/m2 once per week with radiotherapy (RT)
Trial: 26644536
Drug: Cisplatin (CDDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP) 40 mg/m2 once per week with radiotherapy (RT)
Trial: 23250170
Drug: UniFil bond
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UniFil bond with repriming treatment (UF-V and UF-VI)
Trial: 17661864
Drug: Dextromethorphan (DEX)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DEX) 30 mg tablets, administered preoperatively and three times in the first 24 hours post-surgery.
Trial: 17661864
Drug: Placebo (P),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (P), administered following the same schedule as DEX.
Trial: 9989683
Drug: High-oleate meal
RxNorm normalized name: oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-oleate meal (50 g)
Trial: 9989683
Drug: High-palmitate meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-palmitate meal (50 g)
Trial: 9989683
Drug: Low-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat meal (15 g high-oleate oil)
Trial: 7582157
Drug: Local Intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local Intranasal Immunotherapy (LII) with macronized powder Parietaria officinalis pollen in increasing doses
Trial: 367655
Drug: Imipramine (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (10-20 mg)
Trial: 367655
Drug: Scopolamine butylbromide
RxNorm normalized name: Scopolamine butylbromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine butylbromide (10-20 mg)
Trial: 27324724
Drug: Black tea
RxNorm normalized name: black tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black tea tablet + standard treatment
Trial: 25262677
Drug: Water jet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water jet device containing chlorhexidine gel (Silonite®) for home use twice daily
Trial: 25262677
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with recommended oral hygiene measures without water jet usage
Trial: 21908036
Drug: Dalcetrapib 600
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 600 mg/day for 24 months
Trial: 19264836
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine administered at 0, 6 and 14 weeks
Trial: 19264836
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine administered at 6, 10 and 14 weeks
Trial: 16174858
Drug: Estrogen-plus-progestin therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen-plus-progestin therapy (0.625 mg conjugated equine estrogens + 2.5 mg medroxyprogesterone acetate)
Trial: 11823394
Drug: Tramadol 100
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 100 mg with lidocaine 0.5% (3 mg.kg(‐1))
Trial: 7721498
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 20 mg three times daily
Trial: 2248921
Drug: DexSol containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DexSol containing recombinant hEGF and human insulin
Trial: 6113234
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (Prazeapm, Diazepam, Lorazepam, Placebo)
Trial: 30622223
Drug: Group LB:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LB: 20 ml 0.25% levobupivacaine + 0.3 mg (1 ml) buprenorphine
Trial: 30622223
Drug: Group LD:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LD: 20 ml 0.25% levobupivacaine + 4 mg (1 ml) dexamethasone
Trial: 30622223
Drug: Group L:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group L: 20 ml 0.25% levobupivacaine + 1 ml normal saline (NS)
Trial: 28640161
Drug: Intravaginal 0.50%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal 0.50% (6.5 mg) prasterone
Trial: 19679575
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (regular training activity without treatment)
Trial: 12353677
Drug: 0.5% fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% fluorouracil cream for 1 week
Trial: 12353677
Drug: 0.5% fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% fluorouracil cream for 2 weeks
Trial: 12353677
Drug: 0.5% fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% fluorouracil cream for 4 weeks
Trial: 10407503
Drug: Antioxidant vitamins
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamins (150 mg ascorbic acid, 67 mg alpha-tocopherol, 9 mg beta-carotene)
Trial: 10407503
Drug: B group
RxNorm normalized name: meningococcal group B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B group vitamins (1 mg folic acid, 7.2 mg pyridoxine, 0.02 mg cyanocobalamin)
Trial: 6113858
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg terfenadine suspension